Clarity Clinic Launches Healthy Connections Group

Clarity Clinic Launches Healthy Connections Group

April 4, 2023 Sam M 0

Clarity Clinic Launches Healthy Connections GroupClarity Clinic Launches Healthy Connections Group

Clarity Clinic’s Healthy Connections Group Aims to Help Individuals Develop Healthy Relationships.

Clarity Clinic Launches Healthy Connections Group
Clarity Clinic

Clarity Clinic Logo

Clarity Clinic is proud to announce the launch of its new group therapy program, Healthy Connections.  

This group is designed for adults who are seeking support for various mental health concerns. Clarity Clinic understands that relationships can be overwhelming, which is why the Healthy Connections Group aims to create a safe, comforting space for individuals to be able to truly connect with others and gain valuable skills for improving their overall mental well-being. People of all types of backgrounds will be able to share their stories and may be able to identify with what others are going through as well. Healthy Connections also offers multiple benefits, including reduced feelings of loneliness, increased self-esteem, improved communication and interpersonal skills, the ability to identify healthy versus unhealthy behaviors in relationships, and learning how to set and enforce boundaries.  

The group will be facilitated by an experienced Clarity Clinic professional, Carol Briggs, LPC, NCC. Carol states, “My hope is that this group will provide a safe and supportive space for members to feel heard and validated in their relationship concerns while also learning skills to increase self-worth, communicate needs effectively, and gain awareness of the thoughts, feelings, behaviors, and experiences that influence unhealthy patterns or disconnection in relationships.” The therapy approaches that will be used within this group include person-centered, Cognitive Behavioral Therapy (CBT), and Dialectical Behavioral Therapy (DBT). 

For more information about the Healthy Connections Group, please visit Healthy Connections Group (Thursdays @ 6 PM)

About Clarity Clinic     

Clarity Clinic offers leading psychiatry and therapy services with locations throughout Chicagoland, Illinois, and Northwest Indiana. Clarity Clinic is redefining mental health care through a leading network of mental health providers, who thoughtfully guide the whole person on their journey to find clarity and mental wellness by providing exceptional psychiatric and therapeutic care. In-person and online psychiatry and therapy appointments can be scheduled online. 

Individual Adult Psychotherapy & Therapy Treatment- Clarity Clinic (claritychi.com) 

Contact Information:

Ruby Maskey

Digital Marketing Manager, Clarity Clinic

[email protected]

Related Files
Healthy Connections Group.pdf

Original Source:

Clarity Clinic Launches Healthy Connections Group

The post Clarity Clinic Launches Healthy Connections Group first appeared on Enrose Magazine.

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

April 4, 2023 Sam M 0

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug DiscoveryAnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

Acquisition Will Further Enhance AnaBios’ Human Tissue & Cells Portfolio, Help Scientists Expedite Drug Discovery & Further Understanding of Cell Biology

AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington. The purchase of Cell Systems will further enhance AnaBios’ unique human tissue and cells portfolio and help scientists expedite drug discovery and further their understanding of cell biology through access to an expansive array of biologically relevant tools.

Cell Systems offers a wide variety of human primary cells, including endothelial cells from the brain, liver, kidney, eye and lung that have been instrumental in the ongoing assessment of COVID-19. Their liver sinusoidal endothelial cells were recently used in a pivotal study of a novel liver-chip model that rigorously validated the use of the primary cells for this microfluidics application, according to the industry standards set by the International Consortium for Innovation and Quality in Pharmaceutical Development.

AnaBios, a pre-clinical contract research organization focused on translational studies, leverages its advanced technologies to provide human tissue samples, cells and services for the pharmaceutical industry and academic laboratories globally. Human primary cells and tissues provide clinically relevant data to increase the success rate of drug development.

“Cell Systems has decades of experience supplying our highly-cited human primary cells to pharma/biotech companies and universities around the world that enable translational research using 2D and 3D models, microfluidic devices and in organ-chip technology. Our primary cells have been instrumental in research of the blood-brain-barrier, liver biology, kidney function, respiratory biology and much more,” said Jesse Damm, CEO of Cell Systems. “AnaBios is the world leader in providing human-focused tissue samples, primary cells and services, so it makes perfect sense for our customers for Cell Systems and AnaBios to join forces.”

“AnaBios is extremely excited to provide Cell Systems’ primary cells to researchers globally and further enhance the landscape of translational research,” said Dr. Andre Ghetti, CEO of AnaBios. “By maximizing the synergies between our offerings and expertise and Cell System’s human primary cells and media, we will provide enhanced translational tools and reagents to academic, pharmaceutical and biotech researchers and optimize their research programs through enhanced human insights.”

Financing for this transaction was provided by AnaBios’ existing investors, including Ampersand Capital Partners. Financial details regarding the acquisition have not been disclosed. For more information and ordering of Cell System human primary endothelial cells, please refer to http://cell-systems.com/pages/primary-human-cells or contact [email protected].

About AnaBios

Located in San Diego, California, AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies. AnaBios primarily focuses on areas of high, unmet medical need, including cardiac disease, lung disease, CNS disorders, pain and itch. As a preclinical CRO, AnaBios has the most extensive network of hospitals and transplant centers for obtaining human tissue samples from ethically consented donors for ex vivo analysis. For more information about AnaBios, visit http://www.anabios.com.

About Cell Systems

Located in Kirkland, Washington, Cell Systems is laser-focused on providing the highest quality cell biology tools to researchers around the globe. With our expansive inventory of primary human cells and optimized media kits, Cell Systems is an ideal partner to support consistency and reproducibility in research programs while enhancing the biological relevance of the insights. Cell Systems ships next day in the US and priority delivery around the world. For more information about Cell Systems, please visit http://www.cell-systems.com.

About Ampersand Capital Partners

Founded in 1988, Ampersand is a middle-market private equity firm with $3 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. For additional information, visit http://www.ampersandcapital.com or follow us on LinkedIn.

Contact Information:

Gary Watkins

Director of Marketing

[email protected]

8587514309

Original Source:

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

The post AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery first appeared on Enrose Magazine.

Health-ISAC Reached Over 8,000 Global Healthcare Security Professionals in 2022 With Targeted Alerts, Indicators, Intelligence Reports and More